secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0001628280-23-004894
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ApolloMed 2022 revenue $1.14B (+48% YoY), net income $49M, adj. EBITDA $140M
----------------------------------------------------------------------------

- Total revenue $1.14B for 2022, up 48% from $773.9M in 2021.
- Net income attributable to ApolloMed $49.0M; diluted EPS $1.08.
- Adjusted EBITDA $140.0M, up 5% from $133.5M; margin 12.2%.
- Cash and equivalents $288.0M at Dec 31, 2022.
- Conference call scheduled Feb 24, 2023 at 8:30 a.m. ET.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000162828023004894/0001628280-23-004894-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000162828023004894/ameh-20230223.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-004894

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer